0,939  0,002  Genotoxic
0,929  0,004  CYP1A2 substrate
0,892  0,003  UGT1A6 substrate
0,870  0,004  Aldehyde oxidase inhibitor
0,822  0,003  Antimutagenic
0,820  0,004  UGT1A9 substrate
0,819  0,009  Caspase 9 stimulant
0,791  0,008  CYP2C9 substrate
0,787  0,005  12-Lipoxygenase inhibitor
0,777  0,002  Cystathionine beta-synthase inhibitor
0,729  0,003  UGT1A3 substrate
0,750  0,025  Alpha-glucosidase inhibitor
0,725  0,004  UGT1A1 substrate
0,717  0,005  NOS2 expression inhibitor
0,709  0,006  CTGF expression inhibitor
0,720  0,018  Transcription factor NF kappa B inhibitor
0,689  0,005  Histamine release inhibitor
0,691  0,012  Carcinogenic
0,684  0,010  Chemopreventive
0,677  0,004  MAO A inhibitor
0,691  0,019  CYP3A4 substrate
0,672  0,005  Free radical scavenger
0,675  0,010  Sensitization
0,676  0,015  15-Lipoxygenase inhibitor
0,658  0,004  MAO inhibitor
0,657  0,011  Mutagenic
0,661  0,017  TNF expression inhibitor
0,649  0,008  Antioxidant
0,663  0,037  Apoptosis agonist
0,650  0,027  Antineoplastic (breast cancer)
0,620  0,006  UGT1A4 substrate
0,616  0,009  Lipoxygenase inhibitor
0,602  0,007  UDP-glucuronosyltransferase substrate
0,596  0,003  UGT2B15 substrate
0,608  0,023  Antileukemic
0,595  0,012  5 Hydroxytryptamine release inhibitor
0,589  0,011  Caspase 3 stimulant
0,573  0,009  CYP1A2 inhibitor
0,555  0,005  Sulfotransferase substrate
0,558  0,014  AR expression inhibitor
0,547  0,010  Amyloid beta aggregation inhibitor
0,568  0,035  Antineoplastic (lung cancer)
0,557  0,031  Prostaglandin dehydrogenase inhibitor
0,530  0,007  UGT2B4 substrate
0,527  0,008  Peroxidase inhibitor
0,538  0,020  Aryl hydrocarbon receptor agonist
0,522  0,018  Proliferative diseases treatment
0,508  0,013  DNA damaging
0,509  0,021  Ulceration
0,508  0,022  Radioprotector
0,510  0,025  Antihypercholesterolemic
0,506  0,022  Antineoplastic (cervical cancer)
0,489  0,021  Cytostatic
0,500  0,032  Teratogen
0,470  0,004  Estrogen antagonist
0,498  0,032  Prostate cancer treatment
0,478  0,012  RNA-directed DNA polymerase inhibitor
0,467  0,005  GST M1-1 substrate
0,467  0,005  MAO B inhibitor
0,486  0,027  CYP2C19 inhibitor
0,455  0,003  NAD(P)H dehydrogenase (quinone) inhibitor
0,527  0,077  Antiinflammatory
0,457  0,009  Antiseptic
0,459  0,019  Hypoxia-inducible factor 1 alpha inhibitor
0,438  0,004  Estrogen receptor alpha antagonist
0,438  0,007  VCAM1 expression inhibitor
0,478  0,047  Antibacterial
0,444  0,014  Pyruvate kinase inhibitor
0,439  0,010  Monophenol monooxygenase inhibitor
0,451  0,023  ICAM1 expression inhibitor
0,432  0,005  Interleukin 4 antagonist
0,430  0,004  Estrogen receptor beta antagonist
0,432  0,008  Amylase inhibitor
0,446  0,022  Antiamyloidogenic
0,427  0,004  Heat shock protein 90 antagonist
0,432  0,010  Melanin inhibitor
0,428  0,010  Carcinogenic, group 3
0,446  0,028  NOS3 expression inhibitor
0,420  0,005  Neurotrophic factor enhancer
0,442  0,028  Chemoprotective
0,447  0,034  CYP2D6 substrate
0,443  0,032  Antineoplastic (melanoma)
0,441  0,031  Cardioprotectant
0,437  0,029  Antineoplastic (glioma)
0,408  0,005  Alkaline phosphatase inhibitor
0,409  0,005  Glutathione S-transferase substrate
0,424  0,023  Nitric oxide antagonist
0,438  0,038  Embryotoxic
0,437  0,038  Respiratory analeptic
0,443  0,049  Immunosuppressant
0,437  0,046  Antineoplastic (colorectal cancer)
0,397  0,005  Breast cancer-resistant protein inhibitor
0,428  0,037  CYP2C19 substrate
0,425  0,036  Hepatic disorders treatment
0,413  0,025  Tumour necrosis factor alpha release inhibitor
0,400  0,013  Hepatoprotectant
0,394  0,008  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,394  0,013  Skin whitener
0,391  0,012  Tubulin antagonist
0,415  0,037  Spasmolytic
0,423  0,045  Antineoplastic (colon cancer)
0,426  0,051  GABA C receptor rho-3 antagonist
0,409  0,042  Antineoplastic (ovarian cancer)
0,372  0,005  NADPH oxidase inhibitor
0,370  0,007  Heat shock protein 90 alpha antagonist
0,369  0,007  Aldehyde dehydrogenase inhibitor
0,387  0,035  Antineoplastic (non-small cell lung cancer)
0,389  0,037  Cytotoxic
0,350  0,004  Macrophage migration inhibitory factor inhibitor
0,375  0,031  Antihypoxic
0,370  0,029  Antineoplastic (osteosarcoma)
0,444  0,103  DNA polymerase beta inhibitor
0,344  0,005  Carbonic anhydrase XV inhibitor
0,396  0,059  CYP2C9 inhibitor
0,395  0,061  MAP kinase kinase 6 inhibitor
0,353  0,021  P-glycoprotein inhibitor
0,364  0,034  Antineoplastic (glioblastoma multiforme)
0,343  0,014  Lipid peroxidase inhibitor
0,431  0,104  DNA directed DNA polymerase inhibitor
0,346  0,018  UGT2B7 substrate
0,333  0,006  Nitric-oxide synthase stimulant
0,346  0,019  Antihypotensive
0,362  0,036  Antipyretic
0,332  0,007  UGT2B1 substrate
0,355  0,032  Antineoplastic (small cell lung cancer)
0,323  0,004  Photosensitizer
0,355  0,037  Hypoglycemic
0,343  0,028  5 Hydroxytryptamine uptake stimulant
0,320  0,005  Estrogen agonist
0,330  0,016  Interferon gamma antagonist
0,349  0,037  Superoxide dismutase inhibitor
0,319  0,009  Carcinogenic, group 2B
0,367  0,060  Bone diseases treatment
0,348  0,041  Sodium/bile acid cotransporter inhibitor
0,355  0,050  Analeptic
0,340  0,035  Antiparasitic
0,327  0,026  Antihelmintic
0,310  0,009  Antifungal enhancer
0,335  0,036  Antimitotic
0,311  0,015  CYP2B6 inhibitor
0,334  0,040  Antineoplastic (renal cancer)
0,345  0,053  Calcium channel activator
0,331  0,045  Radiosensitizer
0,367  0,081  Antipruritic, allergic
0,296  0,014  Acetylcholinesterase inhibitor
0,287  0,008  Xanthine oxidase inhibitor
0,344  0,065  FMO1 substrate
0,283  0,007  Carbonic anhydrase XIII inhibitor
0,283  0,007  Carbonic anhydrase VI inhibitor
0,298  0,023  Pneumotoxic
0,320  0,046  Cardiovascular analeptic
0,285  0,011  SULT1A3 substrate
0,276  0,005  Gastritis treatment
0,282  0,011  LDLR expression enhancer
0,289  0,019  Topoisomerase II inhibitor
0,327  0,061  Antineoplastic (brain cancer)
0,332  0,067  Antifungal
0,276  0,013  DNA polymerase I inhibitor
0,304  0,042  Antineoplastic (bladder cancer)
0,300  0,039  Antihypertriglyceridemic
0,285  0,024  Antineoplastic (squamous cell carcinoma)
0,268  0,007  Carbonic anhydrase III inhibitor
0,310  0,050  Transcription factor STAT inhibitor
0,328  0,067  Vasodilator, coronary
0,306  0,050  Transcription factor STAT3 inhibitor
0,273  0,021  Protein kinase stimulant
0,312  0,061  Antiosteoporotic
0,260  0,010  VEGF expression inhibitor
0,340  0,091  GST A substrate
0,287  0,038  Platelet adhesion inhibitor
0,255  0,008  Choleretic
0,295  0,050  Vasodilator
0,297  0,052  Antineoplastic (liver cancer)
0,249  0,010  SULT1A1 substrate
0,244  0,009  Histidine decarboxylase inhibitor
0,240  0,011  Toll-Like receptor 2 antagonist
0,276  0,047  Tyrosine 3 hydroxylase inhibitor
0,250  0,020  UGT2B9 substrate
0,252  0,023  Antidote
0,297  0,070  Antineoplastic (pancreatic cancer)
0,242  0,016  ATPase inhibitor
0,229  0,004  Estrogen receptor beta agonist
0,238  0,014  Antihemorrhagic
0,239  0,015  Phobic disorders treatment
0,255  0,032  Insulin sensitizer
0,280  0,058  Vascular (periferal) disease treatment
0,308  0,089  Angiogenesis inhibitor
0,238  0,019  Topoisomerase I inhibitor
0,249  0,031  Protein-tyrosine phosphatase inhibitor
0,226  0,008  HIV-1 integrase (Strand Transfer) inhibitor
0,226  0,011  CF transmembrane conductance regulator agonist
0,294  0,081  Antimycobacterial
0,228  0,017  GABA C receptor rho-2 antagonist
0,218  0,008  HIV-1 integrase (3'-Processing) inhibitor
0,237  0,029  NOS3 expression enhancer
0,264  0,059  Antineoplastic (lymphocytic leukemia)
0,214  0,013  Topoisomerase II alpha inhibitor
0,332  0,131  Calcium channel L-type activator
0,234  0,034  Antineoplastic (carcinoma)
0,230  0,031  Antiviral (Influenza A)
0,265  0,066  Antiprotozoal (Leishmania)
0,218  0,019  Antinephritic
0,234  0,036  Tumour necrosis factor antagonist
0,210  0,013  Growth stimulant
0,206  0,009  TRPA1 agonist
0,209  0,013  Coagulant
0,217  0,021  5-Lipoxygenase inhibitor
0,208  0,013  Androgen antagonist
0,210  0,015  Cyclooxygenase 3 inhibitor
0,272  0,083  Antineoplastic (multiple myeloma)
0,284  0,097  Apoptosis antagonist
0,286  0,101  Thyroid hormone antagonist
0,251  0,067  Antineoplastic (sarcoma)
0,191  0,007  SULT1E1 substrate
0,210  0,026  Protein-tyrosine phosphatase 1B inhibitor
0,215  0,032  Cytokine production inhibitor
0,207  0,024  Alkylator
0,186  0,005  Estradiol 17 beta-dehydrogenase inhibitor
0,218  0,039  Cholinergic
0,226  0,049  Dual specificity phosphatase 3 inhibitor
0,277  0,100  Thyroid hormone beta antagonist
0,191  0,015  Dementia treatment
0,209  0,036  Interleukin 6 antagonist
0,184  0,015  Vascular dementia treatment
0,191  0,023  Antineoplastic antibiotic
0,232  0,064  Antineoplastic enhancer
0,175  0,007  Alpha tubulin antagonist
0,226  0,058  Antiviral (Influenza)
0,178  0,013  Heat shock protein 70 antagonist
0,200  0,035  Carcinogenic, group 1
0,243  0,079  Antidiabetic symptomatic
0,220  0,057  Non-steroidal antiinflammatory agent
0,203  0,041  Cyclooxygenase inhibitor
0,190  0,029  Cholesterol synthesis inhibitor
0,199  0,038  UGT2B10 substrate
0,174  0,017  Beta glucuronidase inhibitor
0,175  0,018  Papain-like protease (SARS coronavirus) inhibitor
0,207  0,051  Dual specificity phosphatase inhibitor
0,253  0,099  FMO3 substrate
0,192  0,038  Cyclooxygenase 1 inhibitor
0,172  0,019  Antineoplastic (uterine cancer)
0,228  0,075  Cyclic AMP phosphodiesterase inhibitor
0,246  0,093  Antituberculosic
0,166  0,014  DOPA decarboxylase inhibitor
0,188  0,037  M18 aspartyl aminopeptidase inhibitor
0,227  0,078  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,201  0,052  Antineoplastic (gastric cancer)
0,212  0,064  Abortion inducer
0,157  0,010  Aldose reductase inhibitor
0,198  0,051  Succinate dehydrogenase inhibitor
0,220  0,074  Interleukin antagonist
0,263  0,116  Antithrombotic
0,152  0,006  Progesterone antagonist
0,256  0,111  CYP3A4 inhibitor
0,164  0,019  Creatine kinase inhibitor
0,259  0,116  Antiallergic
0,151  0,007  ATPase (Vacuolar H+) inhibitor
0,160  0,018  Alcohol dehydrogenase inhibitor
0,188  0,047  Contraceptive
0,154  0,014  Keratolytic
0,167  0,029  Expectorant
0,180  0,043  Antiprotozoal (Coccidial)
0,151  0,014  Carbonic anhydrase V inhibitor
0,161  0,024  Antineoplastic alkaloid
0,222  0,088  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,146  0,013  Beta tubulin antagonist
0,241  0,109  Streptokinase A inhibitor
0,156  0,025  Antiviral (Influenza B)
0,207  0,077  MAP kinase kinase 2 inhibitor
0,149  0,019  Anabolic
0,150  0,020  Electron transport complex I inhibitor
0,171  0,041  Cyclooxygenase 2 inhibitor
0,186  0,057  Antirickettsial
0,141  0,013  Postmenopausal disorders treatment
0,141  0,012  Phosphodiesterase 6D inhibitor
0,221  0,093  DNA synthesis inhibitor
0,131  0,003  Transcription factor RelA inhibitor
0,163  0,037  Antihelmintic (Trematoda)
0,196  0,071  DNA methyltransferase I inhibitor
0,162  0,038  Antibacterial (Helicobacter pylori)
0,139  0,014  CDC25A inhibitor
0,178  0,056  Arachidonic acid antagonist
0,178  0,057  Acaricide
0,152  0,033  Butyrylcholinesterase inhibitor
0,132  0,015  Carbonic anhydrase VA inhibitor
0,153  0,036  Microtubule formation inhibitor
0,182  0,066  Mcl-1 antagonist
0,121  0,006  Estrogen receptor alpha agonist
0,120  0,007  Heat shock protein 90 beta antagonist
0,165  0,053  Mannose-6-phosphate isomerase inhibitor
0,172  0,060  Neurotensin receptor agonist
0,157  0,045  Farnesoid X receptor antagonist
0,123  0,012  Antiviral (Hepatitis A)
0,170  0,059  Phospholipase A2 inhibitor
0,145  0,035  Mucolytic
0,298  0,190  Antineoplastic (solid tumors)
0,123  0,015  Thioredoxin reductase inhibitor
0,141  0,033  Mediator release inhibitor
0,132  0,025  UGT2B11 substrate
0,173  0,066  Antihelmintic (Nematodes)
0,137  0,029  Toll-Like receptor 4 antagonist
0,192  0,085  DNA methylase inhibitor
0,203  0,097  Dyrk kinase inhibitor
0,138  0,033  Antifungal (Pneumocystis)
0,122  0,017  Aromatase inhibitor
0,118  0,015  T cell inhibitor
0,142  0,040  Contraceptive female
0,167  0,065  Antiviral (Herpes)
0,113  0,011  Androgen agonist
0,115  0,014  Phosphodiesterase VI inhibitor
0,102  0,003  ATP citrate lysase inhibitor
0,156  0,061  Hemostatic
0,190  0,095  Cardiodepressant
0,211  0,116  Flavin-containing monooxygenase substrate
0,116  0,022  Cyclin B3 inhibitor
0,110  0,018  SULT1A2 substrate
0,202  0,113  Antiviral (West Nile virus)
0,109  0,020  D-Ala-D-Ala ligase inhibitor
0,117  0,028  CYP2A6 inhibitor
0,205  0,117  Immunostimulant
0,139  0,051  Vanilloid 1 agonist
0,146  0,058  M17 leucyl aminopeptidase inhibitor
0,132  0,044  Chelator
0,218  0,131  Insulysin inhibitor
0,233  0,146  Thioredoxin glutathione reductase inhibitor
0,127  0,041  Multidrug resistance-associated protein 1 inhibitor
0,090  0,004  DNA gyrase subunit A inhibitor
0,105  0,019  MAP3K7 inhibitor
0,145  0,061  Interleukin 1 antagonist
0,121  0,038  Prolactin inhibitor
0,262  0,179  Transcription factor inhibitor
0,184  0,103  Angiogenesis stimulant
0,123  0,042  Urease inhibitor
0,089  0,008  Glucose-6-phosphate translocase inhibitor
0,097  0,017  Carbonic anhydrase VB inhibitor
0,116  0,036  Antifungal (Aspergillus)
0,107  0,027  Granulocyte macrophage colony stimulating factor agonist
0,143  0,063  Ca2+-transporting ATPase inhibitor
0,147  0,068  MAP kinase kinase 4 inhibitor
0,103  0,024  Leukotriene synthesis inhibitor
0,088  0,009  Postcoital contraceptive
0,137  0,060  Antihyperlipoproteinemic
0,179  0,103  Antiviral (Ebola)
0,094  0,018  Xanthine dehydrogenase inhibitor
0,161  0,085  3C-like protease (Human coronavirus) inhibitor
0,112  0,036  Paget's disease treatment
0,106  0,032  Glutathione S-transferase inhibitor
0,162  0,089  Amyloid beta precursor protein antagonist
0,197  0,125  Lipoprotein disorders treatment
0,085  0,015  Carbonic anhydrase XIV inhibitor
0,096  0,027  HIV-1 integrase inhibitor
0,122  0,056  Transcription factor STAT6 inhibitor
0,133  0,069  Antiprotozoal (Trichomonas)
0,116  0,052  AMP-activated protein kinase stimulant
0,111  0,049  GABA C receptor rho-1 antagonist
0,094  0,033  Estrogen-related receptor beta agonist
0,104  0,043  Actinic keratosis treatment
0,105  0,044  ABCA1 expression enhancer
0,119  0,058  DNA intercalator
0,083  0,024  Aryl hydrocarbon receptor antagonist
0,072  0,014  Leukocyte elastase inhibitor
0,072  0,015  Acetyl-CoA transferase 2 inhibitor
0,098  0,042  Tocolytic
0,101  0,046  Bile acid receptor antagonist
0,153  0,098  Catenin beta inhibitor
0,105  0,050  MAP kinase kinase 1 inhibitor
0,068  0,016  Carbonic anhydrase VII inhibitor
0,090  0,038  Telomerase inhibitor
0,110  0,059  Gout treatment
0,079  0,028  Glutamate (mGluR7) antagonist
0,056  0,006  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,059  0,008  Melatonin 2 agonist
0,077  0,026  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,164  0,117  Antiulcerative
0,105  0,059  Bronchodilator
0,054  0,010  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,049  0,005  Estrogen-related receptor beta antagonist
0,113  0,070  Antitussive
0,056  0,013  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,118  0,076  DNA repair enzyme inhibitor
0,093  0,051  Carcinogenic, group 2A
0,085  0,043  Antibiotic
0,129  0,087  Cell wall synthesis inhibitor
0,068  0,027  Fatty acid synthase inhibitor
0,122  0,083  Bone formation stimulant
0,092  0,053  Ornithine decarboxylase inhibitor
0,064  0,026  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,089  0,051  Myeloperoxidase inhibitor
0,059  0,022  Squalene epoxidase inhibitor
0,072  0,035  Andropause treatment
0,093  0,057  Thioredoxin inhibitor
0,076  0,041  Peroxisome proliferator-activated receptor gamma antagonist
0,040  0,006  Inosine monophosphate dehydrogenase 1 inhibitor
0,158  0,124  Growth factor agonist
0,067  0,034  Transcription factor AP-1 inhibitor
0,163  0,130  Antialcoholic
0,048  0,016  Inosine monophosphate dehydrogenase inhibitor
0,063  0,030  Ryanodine receptor antagonist
0,095  0,063  Interleukin 12 antagonist
0,192  0,160  Gastrin inhibitor
0,075  0,045  Glycine receptor agonist
0,069  0,039  Uterine relaxant
0,054  0,025  Mineralocorticoid receptor antagonist
0,129  0,100  Eye irritation, high
0,105  0,077  Interleukin 2 antagonist
0,059  0,031  Elastase inhibitor
0,102  0,075  GABA C receptor antagonist
0,078  0,052  Na+ K+ transporting ATPase inhibitor
0,129  0,104  Adenylate cyclase stimulant
0,040  0,015  Melatonin 1 agonist
0,056  0,034  DNA helicase inhibitor
0,062  0,040  Antidote, heavy metal
0,073  0,053  Phosphodiesterase 4D inhibitor
0,030  0,011  Complement factor 1r inhibitor
0,087  0,071  Protein kinase C zeta inhibitor
0,089  0,074  Interleukin 1 beta converting enzyme inhibitor
0,034  0,021  Estrogen-related receptor alpha antagonist
0,017  0,004  Progesterone receptor A antagonist
0,069  0,056  Histone deacetylase SIRT1 stimulant
0,069  0,056  Histone deacetylase stimulant
0,091  0,079  Skin irritative effect
0,041  0,029  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,066  0,055  Anticholelithogenic
0,066  0,056  SULT2A1 substrate
0,051  0,042  Leukotriene B4 antagonist
0,020  0,013  Inosine monophosphate dehydrogenase 2 inhibitor
0,077  0,069  Caspase 7 inhibitor
0,031  0,025  Melatonin agonist
0,031  0,025  Catechol O-methyltransferase inhibitor
0,065  0,059  Lipase inhibitor
0,060  0,055  Neuraminidase (influenza) inhibitor
0,082  0,079  Uric acid excretion stimulant
0,078  0,075  mTOR complex 2 inhibitor
0,089  0,087  HDL-cholesterol increasing

